65322

ICS capital calculations: onerous, uncertain, but growing in relevance

The global Insurance Capital Standard (ICS) requires yet more modelling work for insurers and some of its rules for calculating capital are vague. It's currently a low priority for insurers and investors, but UK firms in particular should watch closely. Christopher Cundy reports

63929

Insurers report declining solvency ratios following Covid-19 hit

Aegon, Zurich and L&G say declines remain manageable for now

62418

Swiss Re to push ahead with ReAssure IPO

Targets trillion-pound opportunities in closed-book life consolidation

29451

Credit downgrades raise strategic questions for insurers

Investors are questioning the impact of credit downgrades on insurers' Solvency II balance sheets. Hugo Coelho investigates how firms are gauging this risk and why they resist putting a figure on it

28871

UK firms split on interest rate hedging strategy

L&G has put its economic view on the pedestal, moving away from its rivals and challenging analysts who take Solvency II figures more seriously. Callum Tanner reports

23651

Solvency II standard formula 'blind' to negative rates

Insurers required to hold insufficient capital against the risk that rates move further down, Morgan Stanley warns

20061

How a 100% SCR stopped being sufficient capital

Insurers are holding capital buffers larger than the minimum required under Solvency II, but is it the fault of the rules, the regulators or the market? Hugo Coelho reports

18531

UFR drop no knockout blow to large insurers - Morgan Stanley

Analysts gauge impact of cut in Solvency II reference rate on Allianz, Axa and Munich Re

18121

Ageas at odds with regulator over 0% charge for regional government bonds

FSMA tells insurer to treat securities as corporate bond under the standard formula

16751

ESRB locks horns with Eiopa over Solvency II UFR

The ultimate forward rate has been one of Solvency II's least contentious elements – until now. The European Systemic Risk Board is pushing for a revision that could have a dramatic effect on insurers' solvency. Hugo Coelho reports